|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 95 TWD | -0.11% |
|
+1.50% | -1.25% |
Foresee Pharmaceuticals Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 28.41 million compared to TWD 66.98 million a year ago. Net loss was TWD 179.25 million compared to TWD 122.3 million a year ago.
Basic loss per share from continuing operations was TWD 1.52 compared to TWD 1.04 a year ago. Diluted loss per share from continuing operations was TWD 1.52 compared to TWD 1.04 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -1.25% | 396M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
FORESEE PHARMACEUTICALS CO., LTD. 
